American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
10 hedge funds and large institutions have $547K invested in American Oncology Network, Inc. Class A Common Stock in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
67% more funds holding
Funds holding: 6 → 10 (+4)
57% more capital invested
Capital invested by funds: $349K → $547K (+$198K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BW
BIP Wealth
Atlanta,
Georgia
|
+$103K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$60.8K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$32.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19.3K |
| 5 |
Morgan Stanley
New York
|
+$8.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$224 |
| 2 |
JP Morgan Chase
New York
|
-$12 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Applied Capital
Little Rock,
Arkansas
| $206K | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $125K | +$3.63K | +629 | +3% |
|
|
BW
3
BIP Wealth
Atlanta,
Georgia
| $97.7K | +$103K | +17,791 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $57.8K | +$60.8K | +10,535 | New |
|
|
5
Qube Research & Technologies (QRT)
London,
United Kingdom
| $31.1K | +$32.7K | +5,663 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $18.4K | +$19.3K | +3,351 | New |
|
|
7
Morgan Stanley
New York
| $7.87K | +$8.27K | +1,433 | New |
|
|
CFFP
8
Center for Financial Planning
Southfied,
Michigan
| $1.83K | +$1.93K | +334 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1.69K | +$1.75K | +304 | +10,133% |
|
10
Wells Fargo
San Francisco,
California
| $60 | – | – | – |
|
|
11
Barclays
London,
United Kingdom
| – | -$224 | -38 | Closed |
|
|
12
JP Morgan Chase
New York
| – | -$12 | -2 | Closed |
|
AONC Hedge Fund Activity: Q1 2024 in Review
10 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q1 2024, worth a combined $547K — up 57% from $349K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AONC positions and 2 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was BIP Wealth, opening a new position worth an estimated $103K. The largest seller was Barclays, exiting entirely with an estimated $224 sold.
- 10 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q1 2024, up from 6 in Q4 2023.
- Funds reported $547K of American Oncology Network, Inc. Class A Common Stock stock for Q1 2024, up 57% quarter-over-quarter.
- 6 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q1 2024 and 2 closed out, a net change of +4 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q1 2024 was BIP Wealth, an estimated $103K added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q1 2024 was Barclays, an estimated $224 sold.
Based on aggregated 13F filings for Q1 2024.